Fight Fatigue is evaluating the feasibility and acceptability of a combined progressive muscle relaxation and walking intervention to reduce fatigue for adults with end-stage kidney disease receiving in-center hemodialysis.
Diagnosis of ESKD diagnosis and receiving hemodialysis for at least 3 months
Can read and speak English
Fatigue measured via visual analogue scale, score ≥4 over the last week
Able to stand and walk one block
Patient's nephrologist refuses for them to participate
Unstable angina
Unstable pulmonary disease or pulmonary symptoms that preclude participation
Lower-extremity amputation without prosthetic (BKA, AKA) -Orthopedic or neurologic condition that would preclude walking or tensing/releasing of muscles-
Parallel
Fight Fatigue
BehavioralCombined progressive muscle relaxation and walking (increasing step count) 12-week intervention that consists of education/training followed by text messages.
Attention Control
Other interventionEnd-stage kidney disease education
Feasibility of recruitment
Recruitment metrics (enrolled/invited)
Feasibility of retention
Retention in the study from baseline to week 12
Acceptability
Participant rating of acceptability (e.g., enjoyable, easy to understand) via Likert scale questions and open ended questions
Adherence to the study protocol
Adherence to the intervention measured with adherence to step counts, number/duration of accesses on the study-specific website, and adherence to study procedures as evaluated with number of text messages read/sent messages read.
Fatigue
FACIT-Fatigue measure
Click on the lead sponsor to view all of their trials.
University of Illinois at Chicago
Lead sponsor
National Center for Complementary and Integrative Health (NCCIH)
Collaborator
